8 news items
HC Wainwright & Co. Reiterates Buy on Gossamer Bio, Maintains $10 Price Target
GOSS
20 May 24
HC Wainwright & Co. analyst Patrick Trucchio reiterates Gossamer Bio (NASDAQ:GOSS) with a Buy and maintains $10 price target.
Wedbush Reiterates Outperform on Gossamer Bio, Maintains $4 Price Target
GOSS
8 May 24
Wedbush analyst Laura Chico reiterates Gossamer Bio (NASDAQ:GOSS) with a Outperform and maintains $4 price target.
HC Wainwright & Co. Reiterates Buy on Gossamer Bio, Maintains $10 Price Target
GOSS
6 May 24
HC Wainwright & Co. analyst Patrick Trucchio reiterates Gossamer Bio (NASDAQ:GOSS) with a Buy and maintains $10 price target.
Wedbush Assumes Gossamer Bio at Outperform, Announces Price Target of $4
GOSS
5 Apr 24
Wedbush analyst Laura Chico assumes Gossamer Bio (NASDAQ:GOSS) with a Outperform rating and announces Price Target of $4.
Piper Sandler Maintains Overweight on Gossamer Bio, Maintains $15 Price Target
GOSS
27 Mar 24
Piper Sandler analyst Yasmeen Rahimi maintains Gossamer Bio (NASDAQ:GOSS) with a Overweight and maintains $15 price target.
i04zf4b n2aiucaewhr92q4szl
GOSS
6 Mar 24
(NASDAQ:GOSS) and lower its price target from $9.00 to $8.00.
Shares of Gossamer Bio are trading up 0.69% over the last 24 hours, at $1.46 per share
tqrs6gyn
GOSS
6 Mar 24
Goldman Sachs analyst Paul Choi maintains Gossamer Bio (NASDAQ:GOSS) with a Buy and lowers the price target from $9 to $8.
n03t7h1hkhff9qo70g31gr7o90ag76ah5hhafg2z
GOSS
6 Mar 24
HC Wainwright & Co. analyst Patrick Trucchio reiterates Gossamer Bio (NASDAQ:GOSS) with a Buy and maintains $10 price target.
- Prev
- 1
- Next